<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" lang="en">
<head>
<meta http-equiv="default-style" content="application/xhtml+xml; charset=utf-8"/>
<title>Brunner &#38; Suddarth&#8217;s Textbook of Medical-Surgical Nursing, 15e</title>
<link rel="stylesheet" type="text/css" href="style.css"/>
</head>
<body epub:type="bodymatter">
<div id="main_container">
<section epub:type="division">
<h4 class="h4" id="s1337">Latex Allergy</h4>
<p class="nonindent">Latex allergy&#x2014;the allergic reaction to the proteins in the saplike fluid of a rubber tree&#x2014;has been implicated in rhinitis, conjunctivitis, contact dermatitis, urticaria, asthma, and anaphylaxis. The prevalence is estimated at 4% to 7% of the population, but this has been steadily declining because of the use of nonpowdered latex and latex-free gloves (Hamilton, 2017a).</p>
<p class="indent">The sap of the rubber tree (<em>Hevea brasiliensis</em>) contains 250 different polypeptides that can react with IgE. The polypeptides and proteins in natural rubber latex (Hevea proteins) or the various chemicals that are used in the manufacturing process are thought to be the source of the allergic reactions.</p>
<p class="indent">Those at risk include health care workers, patients who have undergone multiple surgeries, people working in factories that manufacture latex products, and patients with spina bifida. Patients with spina bifida are at risk because they have had multiple surgeries, multiple urinary catheterization procedures, and other treatments involving use of latex products (Hamilton, 2017a). Because food handlers, hairdressers, automobile mechanics, and police may wear latex gloves and use latex products, they are also at risk for latex allergy. Increasingly, however, nonlatex gloves are being used in various occupational settings. Risk factors include occupational exposure to latex and atopic tendency in the affected person. Patients are at risk for anaphylactic reactions as a result of contact with latex during medical treatments, particularly surgical procedures (AAAAI, 2019d).</p>
<p class="indent">Persons with latex allergy are also prone to cross-reactions to pollen and some fruits; such as kiwis, bananas, pineapples, mangoes, passion fruit, avocados, and chestnuts (Hamilton, 2017a).</p>
<p class="indent">Routes of exposure to latex products can be cutaneous, percutaneous, mucosal, parenteral, or aerosol. The most frequent source of exposure is cutaneous, which usually involves the wearing of natural latex gloves. The powder used to facilitate putting on latex gloves can become a carrier of latex proteins from the gloves; when the gloves are put on or removed, the particles become airborne and can be inhaled or settle on skin, mucous membranes, or clothing (AAAAI, 2019d). Mucosal exposure can occur from the use of latex condoms, catheters, airways, and nipples. Parenteral exposure can occur from intravenous lines or hemodialysis equipment. In addition to latex-derived medical devices, many household items also contain latex. Examples of medical and household items containing latex and a list of alternative products are found in <a href="#tt33-5">Table 33-5</a>. It is estimated that more than 40,000 medical devices and nonmedical products contain latex (AAAAI, 2019d).</p>
<h5 class="h5" id="s1338">Clinical Manifestations</h5>
<p class="nonindent">Many different types of reactions to latex are possible (see <a href="#tt33-6">Table 33-6</a>). Irritant contact dermatitis, a nonimmunologic response, may be caused by mechanical skin irritation or an alkaline pH associated with latex gloves. Common symptoms of irritant dermatitis include erythema and pruritus.</p>
<p class="indent">Delayed hypersensitivity to latex, a type IV reaction mediated by T cells, is localized to the area of exposure and is characterized by symptoms of contact dermatitis. These include vesicular skin lesions, papules, pruritus, edema, erythema, and crusting and thickening of the skin. These symptoms usually appear on the back of the hands 1 to 4 days postcontact. It is the most common allergic reaction to latex. Although usually not life-threatening, delayed hypersensitivity reactions often <span epub:type="pagebreak" id="page1063" title="1063"></span>require major changes in the patient&#x2019;s home and work environment to avoid further exposure (AAAAI, 2019d).</p>
<div class="table">
<table class="tbo" id="tt33-5">
<colgroup>
<col style="width:20%"></col>
<col style="width:80%"></col>
</colgroup>
<tr>
<td class="tdnum"><p class="tnum"><strong>TABLE&#x00A0;33-5</strong></p></td>
<td><p class="tcaption">Select Products Containing Natural Rubber Latex and Latex-Free Alternatives</p></td>
</tr>
</table>
<table class="table">
<tr><td class="thead"><p class="T2">Products Containing Latex</p></td>
<td class="thead"><p class="T2">Examples of Latex-Safe Alternatives<em><a href="#fn_a" id="ft_a"><sup>a</sup></a></em></p></td></tr>
<tr><td class="td76_line">
<p class="tbodyleft"><strong>Hospital Environment</strong></p></td>
<td class="td76_line"></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Ace bandage (brown)</p></td>
<td class="td76">
<p class="tbodyleft">Ace bandage, white all cotton</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Adhesive bandages, Band-Aid dressing, Telfa</p></td>
<td class="td76">
<p class="tbodyleft">Cotton pads and plastic or silk tape, Active Strips (3M), DuoDERM</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Anesthesia equipment</p></td>
<td class="td76">
<p class="tbodyleft">Neoprene anesthesia kit (King)</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Blood pressure cuff, tubing, and bladder</p></td>
<td class="td76">
<p class="tbodyleft">Clean Cuff, single-use nylon or vinyl blood pressure cuffs or wrap with stockinette or apply over clothing</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Catheters</p></td>
<td class="td76">
<p class="tbodyleft">All-silicone or vinyl catheters</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Catheter leg bag straps</p></td>
<td class="td76">
<p class="tbodyleft">Velcro straps</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Crutch axillary pads and hand grips, tips</p></td>
<td class="td76">
<p class="tbodyleft">Cover with cloth, tape</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">ECG pads</p></td>
<td class="td76">
<p class="tbodyleft">Baxter, Red Dot 3M ECG pads</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Elastic compression stockings</p></td>
<td class="td76">
<p class="tbodyleft">Kendall SCD stockings with stockinette</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Gloves</p></td>
<td class="td76">
<p class="tbodyleft">Derma Prene, neoprene, polymer, or vinyl gloves</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">IV catheters</p></td>
<td class="td76">
<p class="tbodyleft">Jelco, Deseret IV catheters</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">IV rubber injection ports</p></td>
<td class="td76">
<p class="tbodyleft">Cover Y-sites and ports; do not puncture. Use three-way stopcocks on plastic tubing</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Levin tube</p></td>
<td class="td76">
<p class="tbodyleft">Salem sump tube</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Medication vials</p></td>
<td class="td76">
<p class="tbodyleft">Remove rubber stopper</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Penrose drains</p></td>
<td class="td76">
<p class="tbodyleft">Jackson-Pratt, Zimmer Hemovac drains</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Prepackaged enema kits</p></td>
<td class="td76">
<p class="tbodyleft">Therevac, Fleet Ready-to-Use</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Pulse oximeters</p></td>
<td class="td76">
<p class="tbodyleft">Noninoximeters</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Resuscitation bags</p></td>
<td class="td76">
<p class="tbodyleft">Laerdal, Puritan Bennett, <em>certain</em> Ambu</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Stethoscope tubing</p></td>
<td class="td76">
<p class="tbodyleft">PVC tubing; cover with latex-free stockinette</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Suction tubing</p></td>
<td class="td76">
<p class="tbodyleft">PVC (Davol, Laerdal)</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Syringes&#x2014;single use (Monoject, BD)</p></td>
<td class="td76">
<p class="tbodyleft">Terumo syringes, Abbott PCA Abboject</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Tapes</p></td>
<td class="td76">
<p class="tbodyleft">Dermicel, Micropore</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Theraband</p></td>
<td class="td76">
<p class="tbodyleft">New Thera-band Exercisers, plastic tubing</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Thermometer probes</p></td>
<td class="td76">
<p class="tbodyleft">Diatek probe covers</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Tourniquets</p></td>
<td class="td76">
<p class="tbodyleft">X-Tourn straps (Avcor)</p></td></tr>
<tr><td class="td76a_line">
<p class="tbodyleft"><strong>Home Environment</strong></p></td>
<td class="td76a_line"></td></tr>
<tr><td class="td76a">
<p class="tbodyleft">Balloons</p></td>
<td class="td76a">
<p class="tbodyleft">Mylar balloons</p></td></tr>
<tr><td class="td76a">
<p class="tbodyleft">Condoms, diaphragms</p></td>
<td class="td76a">
<p class="tbodyleft">Polyurethane products, Durex Avanti and Reality products (female condom)</p></td></tr>
<tr><td class="td76a">
<p class="tbodyleft">Diapers, incontinence pads</p></td>
<td class="td76a">
<p class="tbodyleft">Huggies, Always, <em>some</em> Attends</p></td></tr>
<tr><td class="td76a">
<p class="tbodyleft">Feminine hygiene pads</p></td>
<td class="td76a">
<p class="tbodyleft">Kimberly-Clark products</p></td></tr>
<tr><td class="td76a">
<p class="tbodyleft">Wheelchair cushions</p></td>
<td class="td76a">
<p class="tbodyleft">ROHO cushions, Sof Care bed/chair cushions</p></td></tr>
</table>
<p class="TABLEpLEGEND"><em><a href="#ft_a" id="fn_a"><sup>a</sup></a></em>Confirmation is essential to verify that all items are latex free before using, especially if risk of latex allergy is present.</p>
<p class="tablesource">ECG, electrocardiogram; IV, intravenous; PVC, polyvinyl chloride.</p>
<p class="tablesource">Adapted from Centers for Disease Control and Prevention (CDC). (2014). Latex allergy: A prevention guide. Retrieved on 12/2/2019 at: <a href="http://www.cdc.gov/niosh/docs/98-113/default.html">www.cdc.gov/niosh/docs/98-113/default.html</a>; Mayo Foundation for Medical Education and Research. (2019). Diseases and conditions: Latex allergy. Retrieved on 12/2/2019 at: <a href="http://www.mayoclinic.org/diseases-conditions/latex-allergy/basics/definition/CON-20024233">www.mayoclinic.org/diseases-conditions/latex-allergy/basics/definition/CON-20024233</a></p>
</div>
<p class="indent">Latex allergy can also be an immediate hypersensitivity, type I allergic reaction, mediated by IgE. Localized itching, erythema, or local urticaria within 10 to 15 minutes after exposure to latex are often the initial symptoms (Hamilton, 2017a). Symptoms commonly include rhinitis, conjunctivitis, and nasal congestion. An asthma attack can be triggered. Severe anaphylaxis can occur, which includes generalized urticaria, angioedema, bronchospasm, and hypotension minutes after dermal or mucosal exposure to latex.</p>
<h5 class="h5" id="s1339">Assessment and Diagnostic Findings</h5>
<p class="nonindent">The diagnosis of latex allergy is based on the history, physical examination, and diagnostic test results. Sensitization is detected by skin testing; serum-specific IgE, EIA, or ELISA; or the level of Hevea latex-specific IgE antibody in the serum. Testing for the chemicals found in the rubber production that makes latex is performed using the patch test. Skin patch testing is the preferred method for patients with contact allergies. The TRUE test and other skin tests should be performed only by primary providers who have expertise in their administration and interpretation and who have the necessary equipment available to treat local or systemic allergic reactions to the reagent (Hamilton, 2017a).</p>
<h5 class="h5" id="s1340">Medical Management</h5>
<p class="nonindent">The best prevention strategy for latex allergy is the avoidance of latex-based products. A new, natural derivative from the desert plant guayule is now being used as a replacement for latex in many products. The predominant nonsterile, nonlatex examination gloves used in medical institutions today are made of nitrile, neoprene, vinyl, or synthetic polyisoprene rubber that is extracted from oil. Nonlatex condoms are available for contraception but these do not prevent transmission of HIV or other sexually transmitted infections (STIs). Persons allergic to latex should be cautioned to not blow up latex balloons or be in enclosed spaces where these are used, as these balloons are still used as decorations (AAAAI, 2019d).</p>
<p class="indent">Patients at risk for an anaphylactic reaction to latex should be instructed to carry auto-injectable epinephrine in case of a reaction (Hamilton, 2017b).</p>
<p class="indent">Patients should report their allergy prior to any medical, dental, gynecologic, or surgical procedure and request a latex-safe environment (Hamilton, 2017b).</p>
<div class="pagebreak_container"><span class="pagebreak">p. 1063</span><div class="rule"></div><span id="page1064" class="pagebreak" epub:type="pagebreak" title="1064">p. 1064</span></div>
<div class="table">
<table class="tbo" id="tt33-6">
<colgroup>
<col style="width:20%"></col>
<col style="width:80%"></col>
</colgroup>
<tr>
<td class="tdnum"><p class="tnum"><strong>TABLE&#x00A0;33-6</strong></p></td>
<td><p class="tcaption">Types of Reactions to Latex</p></td>
</tr>
</table>
<table class="table">
<tr><td class="thead"><p class="T2">Type of Reaction</p></td>
<td class="thead"><p class="T2">Cause</p></td>
<td class="thead"><p class="T2">Signs/Symptoms</p></td>
<td class="thead"><p class="T2">Treatment</p></td></tr>
<tr><td class="td76_line">
<p class="tbodyleft">Irritant contact dermatitis</p></td>
<td class="td76_line">
<p class="tbodyleft">Damage to skin because of irritation and loss of epidermoid skin layer; not an allergic reaction. Can be caused by excessive use of soaps and cleansers, repeated handwashing, inadequate hand drying, mechanical irritation (e.g., sweating, rubbing inside powdered gloves), exposure to chemicals added during the manufacturing of gloves, and alkaline pH of powdered gloves.</p>
<p class="tbodyleft">Reaction may occur with first exposure, is usually benign, and is not life-threatening.</p></td>
<td class="td76_line">
<p class="tbodyleft"><em>Acute:</em> Redness, edema, burning, discomfort, itching</p>
<p class="tbodyleft"><em>Chronic:</em> Dry, thickened, cracked skin</p></td>
<td class="td76_line">
<p class="tbodyleft">Referral for diagnostic testing</p>
<p class="tbodyleft">Avoidance of exposure to irritant</p>
<p class="tbodyleft">Thorough washing and drying of hands</p>
<p class="tbodyleft">Use of powder-free gloves with more frequent changes of gloves</p>
<p class="tbodyleft">Changing glove types</p>
<p class="tbodyleft">Use of water- or silicone-based moisturizing creams, lotions, or topical barrier agents</p>
<p class="tbodyleft">Avoidance of oil- or petroleum-based skin agents with latex products, because they cause breakdown of the latex product</p></td></tr>
<tr><td class="td76a_line">
<p class="tbodyleft">Allergic contact dermatitis</p></td>
<td class="td76a_line">
<p class="tbodyleft">Delayed hypersensitivity (type IV) reaction. Usually affects only area in contact with latex; reaction is usually to chemical additives used in the manufacturing process rather than to latex itself. Cause of reaction is T-cell&#x2013;mediated sensitization to additives of latex.</p>
<p class="tbodyleft">Reaction is not</p>
<p class="tbodyleft">life-threatening and is far more common than a type I reaction.</p>
<p class="tbodyleft">Slow onset; occurs 18&#x2013;24 h after exposure. Resolves within 3&#x2013;4 days after exposure. More severe reactions may occur with subsequent exposures.</p></td>
<td class="td76a_line">
<p class="tbodyleft">Pruritus, erythema, swelling, crusty thickened skin, blisters, other skin lesions</p></td>
<td class="td76a_line">
<p class="tbodyleft">Referral for diagnosis (patch tests) and treatment</p>
<p class="tbodyleft">Thorough washing and drying of hands</p>
<p class="tbodyleft">Use of water- or silicone-based moisturizing creams, lotions, or topical barrier agents</p>
<p class="tbodyleft">Avoidance of oil- or petroleum-based products unless they are latex compatible</p>
<p class="tbodyleft">Avoidance of identified causative agent, because continued exposure to latex products in presence of breaks in skin may contribute to latex protein sensitization</p></td></tr>
<tr><td class="td76_line">
<p class="tbodyleft">Latex allergy</p></td>
<td class="td76_line">
<p class="tbodyleft">Type I IgE-mediated immediate hypersensitivity to plant proteins in natural rubber latex. In sensitized people, antilatex IgE antibody stimulates mast cell proliferation and basophil histamine release. Exposure can be through contact with the skin, mucous membranes, or internal tissues, or through inhalation of traces of powder from latex gloves.</p>
<p class="tbodyleft">Severe reactions usually occur shortly after parenteral or mucous membrane exposure. People with any type I reaction to latex are at high risk for anaphylaxis. Local swelling, redness, edema, itching, and systemic reactions, including anaphylaxis, occur within minutes after exposure.</p></td>
<td class="td76_line">
<p class="tbodyleft">Rhinitis, flushing, conjunctivitis, urticaria, laryngeal edema, bronchospasm, asthma, severe vasodilation angioedema, anaphylaxis, cardiovascular collapse, death</p></td>
<td class="td76_line">
<p class="tbodyleft">Immediate treatment of reaction with epinephrine, fluids, vasopressors, and corticosteroids, and airway and ventilator support, with close monitoring for recurrence for the next 12&#x2013;14 h</p>
<p class="tbodyleft">Prompt referral for diagnostic evaluation</p>
<p class="tbodyleft">Treatment and diagnostic evaluation in latex-free environment</p>
<p class="tbodyleft">Assessment of all patients for symptoms of latex allergy</p>
<p class="tbodyleft">Educating patients and family members about the disorder and the importance of preventing future reactions by avoiding latex (e.g., wearing medical identification, carrying and autoinjector of epinephrine)</p></td></tr>
</table>
<p class="TABLEpLEGEND">IgE, immunoglobulin E.</p>
<p class="tablesource">Adapted from American Academy of Allergy, Asthma, and Immunology (AAAAI). (2019d). Latex Allergy. Retrieved on 7/7/2019 at: <a href="http://www.aaaai.org/conditions-and-treatments/library/allergy-library/latex-allergy">www.aaaai.org/conditions-and-treatments/library/allergy-library/latex-allergy</a></p>
</div>
<h5 class="h5" id="s1341">Nursing Management</h5>
<p class="nonindent">The nurse can assume a pivotal role in the management of latex allergies in both patients and staff. All patients should be asked about latex allergy. Every time an invasive procedure must be performed, the nurse should consider the possibility of latex allergies. Nurses working in operating rooms, intensive care units, short procedure units, and EDs need to pay particular attention to latex allergy (Hamilton, 2017b). See <a href="c14.xhtml">Chapter 14</a>, <a href="c14-sec08.xhtml#ff14-2">Figure 14-2</a>, for a sample latex allergy assessment form.</p>
<p class="indent">Although the type I reaction is the most significant of the reactions to latex, care must be taken in the presence of irritant contact dermatitis and delayed hypersensitivity reaction to avoid further exposure of the person to latex. Patients with latex allergy are advised to notify their health care providers and to wear medical identification. Patients must become knowledgeable about what products contain latex and what products are safe, nonlatex alternatives. They must also become knowledgeable about signs and symptoms of latex allergy and emergency treatment and self-injection of epinephrine in case of allergic reaction (Hamilton, 2017b).</p>
<p class="reviewpH1">CRITICAL THINKING EXERCISES</p>
<div class="review">
<p class="reviewpNL1First"><span class="sblue">1</span> <img class="m" src="images/ipc.png" alt=""/> You are the nurse working in an outpatient walk-in clinic. A 28-year-old patient is newly diagnosed with allergic rhinitis. What nursing and interprofessional assessments are indicated? What interventions, including patient education, will you implement? What interprofessional referrals would be appropriate?</p>
<p class="reviewline"></p>
<p class="reviewpNL1First"><span class="sblue">2</span> <img class="m" src="images/ebp.png" alt=""/> A 44-year-old presents to the emergency department (ED) complaining of dyspnea after eating at a new restaurant. The patient states that this has happened two other times in the past and seems to be worse each time. What is the evidence for management of this patient? Describe the strength of the evidence and criteria used to assess its strength.</p>
</div>
<p class="BIBLIOGRAPHYpTitle"><strong><span epub:type="pagebreak" id="page1065" title="1065"></span>REFERENCES</strong></p>
<p class="TOPICpBIBLIOGRAPHYpPARA">*Asterisk indicates nursing research.</p>
<p class="BIBLIOGRAPHYpREFMGROUPpTITLE">Books</p>
<p class="bib" id="bib2372">Actor, J. K. (2019). <em>Introductory immunology</em> (2nd ed). Philadelphia, PA: Elsevier.</p>
<p class="bib" id="bib2373">Comerford, K. C., &#x0026; Durkin, M. T. (2020). <em>Nursing 2020 drug handbook</em>. Philadelphia, PA: Wolters Kluwer.</p>
<p class="bib" id="bib2374">Habif, T. (2016). <em>Clinical dermatology a color guide to diagnosis and therapy</em> (6th ed.). St Louis, MO: Elsevier.</p>
<p class="bib" id="bib2375">Norris, T. (2019). <em>Porth&#x2019;s pathophysiology: Concepts of altered health states</em> (10th ed.). Philadelphia, PA: Wolters Kluwer.</p>
<p class="BIBLIOGRAPHYpREFMGROUPpTITLE">Journals and Electronic Documents</p>
<p class="bib" id="bib2376">Akdis, M. (2018). Allergen immunotherapy for allergic disease: Therapeutic mechanisms. <em>UpToDate</em>. Retrieved on 6/21/2019 at: <a href="http://www.uptodate.com/contents/allergen-immunotherapy-for-allergic-disease-therapeutic-mechanisms">www.uptodate.com/</a> contents/allergen-immunotherapy-for-allergic-disease-therapeutic-mechanisms</p>
<p class="bib" id="bib2377">American Academy of Allergy, Asthma, and Immunology (AAAAI). (2018). Anaphylaxis. Retrieved on 6/26/19 at: <a href="http://www.aaaai.org/conditions-and-treatments/allergies/anaphylaxis">www.aaaai.org/c</a>onditions-and-treatments/allergies/anaphylaxis</p>
<p class="bib" id="bib2378">American Academy of Allergy, Asthma, and Immunology (AAAAI). (2019a). Atopic march definition. Retrieved on 6/24/2019 at: <a href="http://www.aaaai.org/conditions-and-treatments/conditions-dictionary/atopic-march">www.aaaai.org/conditions-and-treatments/conditions-dictionary/atopic-march</a></p>
<p class="bib" id="bib2379">American Academy of Allergy, Asthma, and Immunology (AAAAI). (2019b). Hives (Urticaria) and Angioedema overview. Retrieved on 6/27/2019 at: <a href="http://www.aaaai.org/conditions-and-treatments/library/allergy-library/hives">www.aaaai.org/conditions-and-treatments/library/allergy-library/hives</a> (urticaria) and angioedema overview.</p>
<p class="bib" id="bib2380">American Academy of Allergy, Asthma, and Immunology (AAAAI). (2019c). Understanding hereditary angioedema overview. Retrieved on 6/27/2019 at: <a href="http://www.aaaai.org/conditions-and-treatments/library/allergy-library/understanding-hereditary-angioedema">www.aaaai.org/conditions-and-treatments/library/allergy-library/understanding-hereditary-angioedema</a></p>
<p class="bib" id="bib2381">American Academy of Allergy, Asthma, and Immunology (AAAAI). (2019d). Latex Allergy. Retrieved on 7/7/2019 at: <a href="http://www.aaaai.org/conditions-and-treatments/library/allergy-library/latex-allergy">www.aaaai.org/conditions-and-treatments/library/allergy-library/latex-allergy</a></p>
<p class="bib" id="bib2382">Andreae, D. A., &#x0026; Schreffler, W. G. (2019). Future diagnostic tools for food allergy. <em>UpToDate</em>. Retrieved on 6/29/2019 at: <a href="http://www.uptodate.com/contents/future-diagnostic-tools-for-food-allergy">www.uptodate.com/contents/future-diagnostic-tools-for-food-allergy</a></p>
<p class="bib" id="bib2383">Asero, R., Tedeschi, A., Marzano, A.V., et al. (2017). Chronic urticaria: A focus on pathogenesis. <em>F1000Res</em>, <em>11</em>(6),1095. doi: 10.12688/f1000research.11546.1. PMID: 28751972; PMCID: PMC5506533. Retrieved from: <a href="https://pubmed.ncbi.nlm.nih.gov/28751972/">https://pubmed.ncbi.nlm.nih.gov/28751972/</a></p>
<p class="bib" id="bib2384">Badri, T., &#x0026; Takov, V. (2019). Montelukast. <em>STAT Pearls</em>. Retrieved on 10/15/2019 at: <a href="http://www.ncbi.nlm.nih.gov/books/NBK459301">www.ncbi.nlm.nih.gov/books/NBK459301</a></p>
<p class="bib" id="bib2385">Berger, W. E., &#x0026; Meltzer, E. O. (2015). Intranasal spray medications for maintenance therapy of allergic rhinitis. <em>American Journal Rhinology &#x0026; Allergy</em>, <em>29</em>(4), 273&#x2013;282.</p>
<p class="bib" id="bib2386">Bircher, A. J. (2018). Exanthematous (maculopapular) drug eruption. <em>UpToDate</em>. Retrieved on 6/26/2019 at: <a href="http://www.uptodate.com/contents/exanthematous-maculopapular-drug-eruption">www.uptodate.com/contents/exanthematous-maculopapular-drug-eruption</a></p>
<p class="bib" id="bib2387">Burks, W. (2019). Clinical manifestations of food allergy: An overview. <em>UpToDate</em>. Retrieved on 10/15/2019 at: <a href="http://www.uptodate.com/contents/clinical-manifestations-of-food-allergy-an-overview">www.uptodate.com/contents/clinical-manifestations-of-food-allergy-an-overview</a></p>
<p class="bib" id="bib2388">Campbell, R. L., &#x0026; Kelso, J. M. (2018). Anaphylaxis: Emergency treatment. <em>UpToDate</em>. Retrieved on 10/13/2019 at: <a href="http://www.uptodate.com/contents/anaphylaxis-emergency-treatment">www.uptodate.com/contents/anaphylaxis-emergency-treatment</a></p>
<p class="bib" id="bib2389">Castells, M. C. (2017). Mast cell-derived mediators. <em>UpToDate</em>. Retrieved on 6/20/2019 at: <a href="http://www.uptodate.com/contents/mast-cell-derived-mediators">www.uptodate.com/contents/mast-cell-derived-mediators</a></p>
<p class="bib" id="bib2390">Castells, M. C., &#x0026; Solensky, R. (2017). Rapid drug desensitization for immediate hypersensitivity reactions. <em>UpToDate</em>. Retrieved on 6/26/2019 at: <a href="http://www.uptodate.com/contents/rapid-drug-desensitization-for-immediate-hypersensitivity-reactions">www.uptodate.com/contents/rapid-drug-desensitization-for-immediate-hypersensitivity-reactions</a></p>
<p class="bib" id="bib2391">Centers for Disease Control and Prevention (CDC). (2014). Latex allergy: A prevention guide. Retrieved on 12/2/2019 at: <a href="http://www.cdc.gov/niosh/docs/98-113/default.html">www.cdc.gov/niosh/docs/98-113/default.html</a></p>
<p class="bib" id="bib2392">Centers for Disease Control and Prevention (CDC)/National Center for Health Statistics. (2017). Allergies and Hay fever. Retrieved on 10/13/2019 at: <a href="http://www.cdc.gov/nchs/fastats/allergies.htm">www.cdc.gov/nchs/fastats/allergies.htm</a></p>
<p class="bib" id="bib2393">Chaaban, M. R., Mansi, A., Tripple, J. W., et&#x00A0;al. (2019). SCIT versus SLIT: Which one do you recommend, doc? <em>American Journal of Medical Sciences</em>, <em>357</em>(5), 442&#x2013;447.</p>
<p class="bib" id="bib2394">Chauchan, B. F., Jeyaraman, M. M., Singh Mann, A., et&#x00A0;al. (2017). Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma. <em>Cochrane Database Systematic Reviews</em>, <em>3</em>, CD010347.</p>
<p class="bib" id="bib2395">Cho, Y. T., &#x0026; Chu, C. Y. (2017). Treatments for severe cutaneous adverse reactions. <em>Journal of Immunological Research</em>, <em>2017</em> (1503709). Retrieved on 10/15/2019 at: <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763067">www.ncbi.nlm.nih.gov/pmc/articles/PMC5763067</a></p>
<p class="bib" id="bib2396">Cicardi, M., &#x0026; Zuraw, B. (2018a). Hereditary angioedema: Pathogenesis and diagnosis. <em>UpToDate</em>. Retrieved on 6/27/2019 at: <a href="http://www.uptodate.com/contents/hereditary-angioedema-pathogenesis-and-diagnosis">www.uptodate.com/contents/hereditary-angioedema-pathogenesis-and-diagnosis</a></p>
<p class="bib" id="bib2397">Cicardi, M., &#x0026; Zuraw, B. (2018b). Hereditary angioedema: Treatment of acute attacks. <em>UpToDate</em>. Retrieved on 6/27/2019 at: <a href="http://www.uptodate.com/contents/hereditary-angioedema-treatment-of-acute-attacks">www.uptodate.com/contents/hereditary-angioedema-treatment-of-acute-attacks</a></p>
<p class="bib" id="bib2398">Commins, S. P. (2019). Food intolerance and food allergy in adults. An overview. <em>UpToDate</em>. Retrieved on 6/29/2019 at: <a href="http://www.uptodate.com/contents/food-intolerance-and-food-allergy-in-adults-an-overview">www.uptodate.com/contents/food-intolerance-and-food-allergy-in-adults-an-overview</a></p>
<p class="bib" id="bib2399">deShazo, R. D., &#x0026; Kemp, S. F. (2017). Pathogenesis of allergic rhinitis (rhinosinusitis). <em>UpToDate</em>. Retrieved on 6/20/2019 at: <a href="http://www.uptodate.com/contents/pathogenesis-of-allergic-rhinitis">www.uptodate.com/contents/pathogenesis-of-allergic-rhinitis</a></p>
<p class="bib" id="bib2400">deShazo, R. D., &#x0026; Kemp, S. F. (2018a). Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis. <em>UpToDate</em>. Retrieved on 6/20/2019 at: <a href="http://www.uptodate.com/contents/allergic-rhinitis-clinical-manifestations-epidemiology-and-diagnosis">www.uptodate.com/contents/allergic-rhinitis-clinical-manifestations-epidemiology-and-diagnosis</a></p>
<p class="bib" id="bib2401">deShazo, R. D., &#x0026; Kemp, S. F. (2018b). Pharmacotherapy of allergic rhinitis. <em>UpToDate</em>. Retrieved on 6/20/2019 at: <a href="http://www.uptodate.com/contents/pharmacotherapy-of-allergic-rhinitis">www.uptodate.com/contents/pharmacotherapy-of-allergic-rhinitis</a></p>
<p class="bib" id="bib2402">Durham, S. R., &#x0026; Penagos, M. (2016). Sublingual or subcutaneous immunotherapy for allergic rhinitis? <em>Journal of Allergy and Clinical Immunology</em>, <em>137</em>(2), 339&#x2013;349.</p>
<p class="bib" id="bib2403">Fick, D. M., Semla, T. P., Steinman, M., et&#x00A0;al. (2019). American Geriatrics Society 2019 updated AGS Beers Criteria&#x00AE; for potentially inappropriate medication use in older adults. <em>Journal of the American Geriatrics Society</em>, <em>67</em>(4), 674&#x2013;694.</p>
<p class="bib" id="bib2404">Fornacier, L., &#x0026; Noor, I. (2018). Contact dermatitis and patch testing for the allergist. <em>Annals of Allergy, Asthma, &#x0026; Immunology</em>, <em>120</em>(6), 592&#x2013;598.</p>
<p class="bib" id="bib2405">Goldner, R., &#x0026; Fransway, A. F. (2018). Irritant contact dermatitis in adults. <em>UpToDate</em>. Retrieved on 6/24/2019 at: <a href="http://www.uptodate.com/contents/irritant-contact-dermatitis-in-adults">www.uptodate.com/contents/irritant-contact-dermatitis-in-adults</a></p>
<p class="bib" id="bib2406">Gupta, R. S., Warren, C. M., &#x0026; Smith, B. M. (2019). Prevalence and severity of food allergies among US adults. <em>Journal of the American Medical Association Network Open</em>, <em>2</em>(1), e185630.</p>
<p class="bib" id="bib2407">Guyer, A. C., &#x0026; Banerji, A. (2019). ACE-inhibitor induced angioedema. <em>UpToDate</em>. Retrieved on 6/27/2019 at: <a href="http://www.uptodate.com/contents/ace-inhibitor-induced-angioedema">www.uptodate.com/contents/ace-inhibitor-induced-angioedema</a></p>
<p class="bib" id="bib2408">Hamilton, R. G. (2017a). Latex allergy: Epidemiology, clinical manifestations, and diagnosis. <em>UpToDate</em>. Retrieved on 7/8/2019 at: <a href="http://www.uptodate.com/contents/latex-allergy-epidemiology-clinical-manifestations-and-diagnosis">www.uptodate.com/</a> contents/latex-allergy-epidemiology-clinical-manifestations-and-diagnosis</p>
<p class="bib" id="bib2409">Hamilton, R. G. (2017b). Latex allergy: Management. <em>UpToDate</em>. Retrieved on 7/8/2019 at: <a href="http://www.uptodate.com/contents/latex-allergy-management">www.uptodate.com/contents/latex-allergy-management</a></p>
<p class="bib" id="bib2410">High, W. A. (2019). Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis. <em>UpToDate</em>. Retrieved on 10/15/2019 at: <a href="http://www.uptodate.com/contents/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis">www.uptodate.com/contents/</a> stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis</p>
<p class="bib" id="bib2411">Hill, D. A., &#x0026; Spergel, J. M. (2018). The atopic march: Critical evidence and clinical relevance. <em>Annals of Allergy, Asthma, &#x0026; Immunology</em>, <em>120</em>(2), 131&#x2013;137.</p>
<p class="bib" id="bib2412">James, C., &#x0026; Bernstein, D. (2017). Allergen immunotherapy: An updated review of safety. <em>Current Opinion Allergy Clinical Immunology</em>, <em>17</em>(1), 55&#x2013;59.</p>
<p class="bib" id="bib2413">Kakli, H. A., &#x0026; Riley, T. D. (2016). Allergic rhinitis. <em>Primary Care</em>, <em>43</em>(3), 465&#x2013;475.</p>
<p class="bib" id="bib2414">Kemp, S. F. (2018). Pathophysiology of anaphylaxis. <em>UpToDate</em>. Retrieved on 6/20/2019 at: <a href="http://www.uptodate.com/contents/pathophysiology-of-anaphylaxis">www.uptodate.com/contents/pathophysiology-of-anaphylaxis</a></p>
<p class="bib" id="bib2415">Khan, D. A. (2019a). Chronic spontaneous urticaria: Standard management and patient education. <em>UpToDate</em>. Retrieved on 6/27/2019 at: <a href="http://www.uptodate.com/contents/chronic-spontaneous-urticaria-standard-management-and-patient-eucation">www.uptodate.com/contents/chronic-spontaneous-urticaria-standard-management-and-patient-eucation</a></p>
<p class="bib" id="bib2416">Khan, D. A. (2019b). Chronic spontaneous urticaria: Treatment of refractory symptoms. <em>UpToDate</em>. Retrieved on 6/27/2019 at: <a href="http://www.uptodate.com/contents/chronic-spontaneous-urticaria-treatment-of-refractory-symptoms">www.uptodate.com/contents/chronic-spontaneous-urticaria-treatment-of-refractory-symptoms</a></p>
<p class="bib" id="bib2417">Klimek, L., Pfaar, O., Bousquet, J., et&#x00A0;al. (2017). Allergen immunotherapy in allergic rhinitis: Current use and future trends. <em>Expert Review Clinical Immunology</em>, <em>13</em>(9), 897&#x2013;906.<span epub:type="pagebreak" id="page1066" title="1066"></span></p>
<p class="bib" id="bib2418">Kowal, K., &#x0026; DuBuske, L. (2016). Overview of skin testing for allergic disease. <em>UpToDate</em>. Retrieved on 6/20/2019 at: <a href="http://www.uptodate.com./contents/overview-of-skin-testing-for-allergic-disease">www.uptodate.com./contents/overview-of-skin-testing-for-allergic-disease</a></p>
<p class="bib" id="bib2419">Kowal, K., &#x0026; DuBuske, L. (2017). Overview of in vitro allergy tests. <em>UpToDate</em>. Retrieved on 6/20/2019 at: <a href="http://www.uptodate.com/contents/overview-of-in-vitro-allergy-tests">www.uptodate.com/contents/overview-of-in-vitro-allergy-tests</a></p>
<p class="bib" id="bib2420">Laccourreye, O., Werner, A., Giroud, J. P., et&#x00A0;al. (2015). Benefits, limits, and danger of ephedrine and pseudoephedrine as nasal decongestants. <em>European Annals of Otorhinology and Head &#x0026; Neck Disease</em>, <em>132</em>(1), 31&#x2013;34.</p>
<p class="bib" id="bib2421">Larsen, J. N., Broge, L., &#x0026; Jacobi, H. (2016). Allergy immunotherapy: The future of allergy treatment. <em>Drug Discoverv Today</em>, <em>21</em>(1), 26&#x2013;37.</p>
<p class="bib" id="bib2422">Lieberman, P. L. (2018). Biphasic and protracted anaphylaxis. <em>UpToDate</em>. Retrieved on 6/20/2019 at: <a href="http://www.uptodate.com/contents/biphasic-and-protracted-anaphylaxis">www.uptodate.com/contents/biphasic-and-protracted-anaphylaxis</a></p>
<p class="bib" id="bib2423">Litchman, G., Nair, P. A., &#x0026; Atwater, A. R. (2019). Contact dermatitis. STAT Pearls. Treasure Island, Fla: STAT Pearls. Retrieved on 10/15/2019 at: <a href="http://www.ncbi.nlm.nih.gov/books/NBK459230">www.ncbi.nlm.nih.gov/books/NBK459230</a></p>
<p class="bib" id="bib2424">L&#x2298;set, M., Brown, S. J., Saunes, M., et&#x00A0;al. (2019). Genetics of atopic sermatitis: From DNA sequence to clinical relevance. <em>Dermatology</em>, <em>235</em>(5), 355&#x2013;364.</p>
<p class="bib" id="bib2425">Marshall, J. S., Warrington, R., Watson, W., et&#x00A0;al. (2018). An introduction to immunology and immunopathology. <em>Allergy, Asthma, and Clinical Immunology</em>, <em>14</em>(Suppl 2), 49.</p>
<p class="bib" id="bib2426">Maurer, M. (2019). Cold urticaria. <em>UpToDate</em>. Retrieved on 6/27/2019 at: <a href="http://www.uptodate.com/contents/cold-urticaria">www.uptodate.com/contents/cold-urticaria</a></p>
<p class="bib" id="bib2427">McDonald, M., &#x0026; Sexton, D. J. (2019). Drug fever. <em>UpToDate</em>. Retrieved on 10/15/2019 at: <a href="http://www.uptodate.com/contents/drug-fever">www.uptodate.com/contents/drug-fever</a></p>
<p class="bib" id="bib2428">Mockenhaupt, M. (2019). Drug reaction with eosinophilia and systemic symptoms (DRESS). <em>UpToDate</em>. Retrieved on 10/14/2019 at: <a href="http://www.uptodate.com/contents/drug-reaction-with-eosinophilia-and-systemic-symptoms-dress">www.uptodate.com/contents/drug-reaction-with-eosinophilia-and-systemic-symptoms-dress</a></p>
<p class="bib" id="bib2429">Moore, L. E., Kemp, A. M., Kemp, S. F. (2015). Recognition, treatment, and prevention of anaphylaxis. <em>Immunology and Allergy Clinics of North America</em>, <em>35</em>(2), 363&#x2013;374.</p>
<p class="bib" id="bib2430">Nelson, H. (2018). SCIT: Standard schedules, administration techniques, adverse reactions, and monitoring. <em>UpToDate</em>. Retrieved on 6/21/2019 at: <a href="http://www.uptodate.com/contents/scit-standard-schedules-administration-techniques-adverse-reactions-and-monitoring">www.uptodate.com/contents/scit-standard-schedules-administration-techniques-adverse-reactions-and-monitoring</a></p>
<p class="bib" id="bib2431">Nowak-Wegrzyn, A. (2019). Investigational therapies for food allergy: Immunotherapy and nonspecific therapies. <em>UpToDate</em>. Retrieved on 6/21/2019 at: <a href="http://www.uptodate.com/contents/investigational-therapies-for-food-allergy-immunotherapy-and-nonspecific-therapies">www.uptodate.com/contents/investigational-therapies-for-food-allergy-immunotherapy-and-nonspecific-therapies</a></p>
<p class="bib" id="bib2432">*Pestotnik, G., &#x0026; Krueger, D. (2018). Comparing the discomfort and application time of allergy testing. <em>American Academy of Ambulatory Care Nurses Viewpoint</em>, <em>40</em>(1), 4&#x2013;8.</p>
<p class="bib" id="bib2433">Pichler, W. J. (2019). Drug hypersensitivity: Classification and clinical features. <em>UpToDate</em>. Retrieved on 6/26/2019 at: <a href="http://www.uptodate.com/contents/drug-hypersensitivity-classification-and-clinical-features">www.uptodate.com/contents/drug-hypersensitivity-classification-and-clinical-features</a></p>
<p class="bib" id="bib2434">Pitsios, C., &#x0026; Dietis, N. (2019). Ways to increase adherence to allergen immunotherapy. <em>Current Medical and Research Opinion</em>, <em>35</em>(6), 1027&#x2013;1031.</p>
<p class="bib" id="bib2435">Platts-Mills, T. A. (2019). Allergen avoidance in the treatment of asthma and allergic rhinitis. <em>UpToDate</em>. Retrieved on 6/21/2019 at: <a href="http://www.uptodate.com/contents/allergen-avoidance-in-the-treatment-of-asthma-and-allergic-rhinitis">www.uptodate.com/contents/allergen-avoidance-in-the-treatment-of-asthma-and-allergic-rhinitis</a></p>
<p class="bib" id="bib2436">Randall, K. L., &#x0026; Hawkins, C. A. (2018). Antihistamines and allergy. <em>Australian Prescriber</em>, <em>41</em>(2), 41&#x2013;45.</p>
<p class="bib" id="bib2437">Samel, A. D., &#x0026; Chu, C. Y. (2019). Drug eruptions. <em>UpToDate</em>. Retrieved on 10/15/2019 at: <a href="http://www.uptodate.com/contents/drug-eruptions">www.uptodate.com/contents/drug-eruptions</a></p>
<p class="bib" id="bib2438">Sanchez-Borges, M., &#x0026; Ansotegui, I. J. (2019). Second-generation antihistamines: An update. <em>Current Opinion in Allergy &#x0026; Clinical Immunology</em>, <em>19</em>(4), 358&#x2013;364.</p>
<p class="bib" id="bib2439">Scadding, G. (2017). Rhinitis and rhinosinusitis: When to think allergy and what to do. <em>Practice Nursing</em>, <em>28</em>(11), 472&#x2013;480.</p>
<p class="bib" id="bib2440">Shenoy, E. S., Macy, E., Rowe, T., et&#x00A0;al. (2019). Evaluation and management of penicillin allergy: A review. <em>JAMA</em>, <em>321</em>(2), 188&#x2013;199.</p>
<p class="bib" id="bib2441">Sicherer, S. H. (2019). Management of food allergy: Avoidance. <em>UpToDate</em>. Retrieved on 6/29/2019 at: <a href="http://www.uptodate.com/contents/management-of-food-allergy-avoidance">www.uptodate.com/contents/management-of-food-allergy-avoidance</a></p>
<p class="bib" id="bib2442">Singleton, R., &#x0026; Halverstam, C. P. (2016). Diagnosis and management of cold urticaria. <em>Cutis</em>, <em>97</em>(1), 59&#x2013;62.</p>
<p class="bib" id="bib2443">Song, T. T., &#x0026; Lieberman, P. (2019). Who needs to carry an epinephrine autoinjector? <em>Cleveland Clinical Journal of Medicine</em>, <em>86</em>(1), 66&#x2013;72.</p>
<p class="bib" id="bib2444">Spergel, J. M., &#x0026; Lio, P. A. (2019). Management of severe atopic dermatitis (eczema) in children. <em>UpToDate</em>. Retrieved on 6/26/2019 at: <a href="http://www.uptodate.com/contents/management-of-severe-atopic-dermatitis-eczema-in-children">www.uptodate.com/contents/management-of-severe-atopic-dermatitis-eczema-in-children</a></p>
<p class="bib" id="bib2445">Stokes, J., &#x0026; Casale, T. B. (2018). Anti-IgE therapy. <em>UpToDate</em>. Retrieved on 6/27/2019 at: <a href="http://www.uptodate.com/contents/anti-ige-therapy">www.uptodate.com/contents/anti-ige-therapy</a></p>
<p class="bib" id="bib2446">Stokes, J., &#x0026; Casale, T. B. (2019). The relationship between Ig E and allergic disease. <em>UpToDate</em>. Retrieved on 6/20/2019 at: <a href="http://www.uptodate.com/contents/the-relationship-between-ige-and-allergic-disease">www.uptodate.com/contents/the-relationship-between-ige-and-allergic-disease</a></p>
<p class="bib" id="bib2447">Sundquist, B. K., Lang, B., &#x0026; Pasha, M. A. (2019). Experience in patch testing: A 6 year retrospective review from a single academic allergy practice. <em>Annals of Allergy, Asthma, &#x0026; Immunology</em>, <em>122</em>(5), 502&#x2013;507.</p>
<p class="bib" id="bib2448">Tanno, L. K., Torres, M. J., Castells, M., et&#x00A0;al. (2018). What can we learn in drug allergy management from World Health Organization&#x2019;s international classifications? <em>Allergy</em>, <em>73</em>(5), 987&#x2013;992.</p>
<p class="bib" id="bib2449">U.S. Federal Drug Administration (FDA). (2017). Legal requirements for the sale of drug products containing pseudoephedrine, ephedrine, and phenylpropanolamine. Retrieved on 6/23/2019 at: <a href="http://www.fda.gov/drugs/information-drug-class/legal-requirements-sale-and-purchase-drug-products-containing-pseudoephedrine-ephedrine-and-phenylpropanolamine">www.fda.gov/drugs/information-drug-class/legal-requirements-sale-and-purchase-drug-products-containing-pseudoephedrine-ephedrine-and-phenylpropanolamine</a></p>
<p class="bib" id="bib2450">Wahid, N. W. B., &#x0026; Shermetaro, C. (2019). Rhinitis medicamentosa. STAT Pearls. Retrieved on 10/15/2019 at: <a href="http://www.ncbi.nlm.nih.gov/pubmed/30855902">www.ncbi.nlm.nih.gov/pubmed/30855902</a></p>
<p class="bib" id="bib2451">Warrell, D. A. (2019). Venomous bites, stings, and poisoning: An update. <em>Infectious Disease Clinic of North America</em>, <em>33</em>(1), 17&#x2013;38.</p>
<p class="bib" id="bib2452">Wener, M. H. (2018). Serum sickness and serum sickness-like reactions. <em>UpToDate.</em> Retrieved on 10/15/2019 at: <a href="http://www.uptodate.com/contents/serum-sickness-and-serum-sickness-like-reactions">www.uptodate.com/contents/serum-sickness-and-serum-sickness-like-reactions</a></p>
<p class="bib" id="bib2453">Weston, W. L., &#x0026; Howe, W. (2019). Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis. <em>UpToDate</em>. Retrieved on 6/26/2019 at: <a href="http://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis">www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis</a></p>
<p class="bib" id="bib2454">*Wilkin, Z. L. (2020). Effects of video discharge instructions on patient understanding. <em>Advanced Emergency Nursing Journal</em>, <em>42</em>(1), 71&#x2013;78. <a href="http://www.aaaai.org/conditions-and-treatments/conditions-dictionary/hives">www.aaaai.org/conditions-and-treatments/conditions-dictionary/hives</a></p>
<p class="bib" id="bib2455">Zuraw, B. (2019). An overview of angioedema: Clinical features, diagnosis, and management. <em>UpToDate</em>. Retrieved on 10/15/2019 at: <a href="http://www.uptodate.com/contents/an-overview-of-angioedema-clinical-features-diagnosis-and-management">www.uptodate.com/contents/an-overview-of-angioedema-clinical-features-diagnosis-and-management</a></p>
<p class="BIBLIOGRAPHYpREFMGROUPpTITLE">Resources</p>
<p class="bib" id="bib2456">American Academy of Allergy, Asthma, and Immunology (AAAAI), <a href="http://www.aaaai.org">www.aaaai.org</a></p>
<p class="bib" id="bib2457">Asthma and Allergy Foundation of America (AAFA), <a href="http://www.aafa.org">www.aafa.org</a></p>
<p class="bib" id="bib2458">Asthma and Allergy Foundation of America. (2021). Find a local support group. Retrieved from: <a href="https://www.aafa.org/aafa-affiliated-asthma-allergy-support-groups/">https://www.aafa.org/aafa-affiliated-asthma-allergy-support-groups/</a></p>
<p class="bib" id="bib2459">Food Allergy Research Education (FARE), <a href="http://www.foodallergy.org">www.foodallergy.org</a></p>
<p class="bib" id="bib2460">Mayo Foundation for Medical Education and Research, <a href="http://www.mayoclinic.org">www.mayoclinic.org</a></p>
<p class="bib" id="bib2461">National Institute of Allergy and Infectious Diseases, <a href="http://www.niaid.nih.gov">www.niaid.nih.gov</a></p>
<p class="bib" id="bib2462">Occupational Safety and Health Administration (OSHA), <a href="http://www.osha.gov">www.osha.gov</a></p>
</section>
</div>
</body>
</html>